Neurovinterventional Innovation

Proof-of-Concept #1: “Project Chameleon”

Our lead neurointerventional platform represents a novel technology aimed at addressing critical unmet procedural needs in neurovascular care. Through proprietary engineering approaches, we're developing solutions to enhance procedural performance and improve outcomes across diagnostic and therapeutic applications

Timeline

  • Platform architecture & feasibility framing initiated.

    (Q4 2024)

  • Core engineering team onboarded.

    (Q1 2025)

  • “Patent Pending”; provisional patent filed.

    (Q2 2025)

  • On track for non-provisional application filing.

    (Q1 2026)

Updates

  • Technical feasibility validated. (Milestone 1)

  • Core platform integration development underway. (Milestone 2)

Proof-of-Concept #2: “Project Thrombosis”

Our secondary neurointerventional innovation represents novel technology aimed at addressing critical unmet device needs in neurovascular care. Through proprietary engineering approaches, we're developing solutions to enhance device performance and improve outcomes across diagnostic and therapeutic applications.

Timeline

  • Platform architecture & feasibility framing initiated.

    (Q2 2025)

  • Core engineering team onboarded.

    (Q3 2025)

  • “Patent Pending”; provisional patent filed.

    (Q4 2025)

  • Anticipated non-provisional application filing.

    (Q3 2026)

Updates

  • Technical feasibility validation in progress.

    (Milestone 1)